For HS patients using a GLP-1 RA for six months, the researchers found: Less severe HS: 54% of participants improved by one point and 12% improved by two or more points on the HS-PGA (Hidradenitis Suppurativa Physician Global Assessment) scale, which measures general severity of HS on a scale from 0 to 5
However, GLP-2 is the hormone, whereas tirzepatide is the weight-loss peptide
Did a supplement containing vitamin C, zinc, and other antioxidant ingredients help reduce eye floaters in a recent study
For behavioral studies, data were analyzed by ANCOVA, or repeated-measures one-way or two-way ANOVA followed by Tukeys or Bonferronis post hoc test as appropriate
Zhang L, Tian J, Diao S, et al